Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Eur J Endocrinol. 2022 May 12;187(1):49–64. doi: 10.1530/EJE-21-1183

Figure 5. The SCT transcriptome is distinct from that of macroadenomas.

Figure 5.

(A-B) Individual analysis of a silent gonadotroph macroadenoma (SGT-macro, A), and a FCT-macro (FCT4, B) demonstrating the cellular composition, and well-differentiated features of the tumor cells with expression of transcripts associated with secretory function. (C-D) Depiction of the relative similarity in expression of a series of secretory (C) and EMT-associated (D) transcripts in 3 FCT-micros (FCT1-3, blue box), a FCT-macro (FCT4, black box), and a SGT-macro (red box), and their striking difference to expression levels of these transcripts in SCTs (yellow box).